Please login to the form below

Not currently logged in
Email:
Password:

Xgeva

This page shows the latest Xgeva news and features for those working in and with pharma, biotech and healthcare.

Amgen buys BeiGene stake for $2.7bn to aid push into China

Amgen buys BeiGene stake for $2.7bn to aid push into China

BeiGene will sell  Xgeva (denosumab) for cancer that has spread to the bones, multiple myeloma therapy  Kyprolis(carfilzomib) and  Blincyto (blinatumomab) for leukaemia in China on a profit-sharing basis, according ... Xgeva was launched in China in

Latest news

More from news
Approximately 3 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics